Language selection

Government of Canada / Gouvernement du Canada

Search

Isolation and characterization of anti-SLP single domain antibodies for the therapy of C. difficile infection

From National Research Council Canada

Download
  1. (PDF, 7.5 MiB)
AuthorSearch for:
FormatText, Thesis
Physical description157 p.
Abstract
Clostridium difficile is the leading cause of death from gastrointestinal infections in Canada. Current antiobiotic treatment is non-ideal due to the high incidence of relapse and the rise in hyper-virulent antibiotic-resistant strains. Surface layer proteins (SLPs) cover the entire bacterial surface and mediate adherence to host cells. Passive and active immunization against SLPs greatly enhances survival in hamsters, suggesting that antibody-mediated bacterial neutralization may be an effective alternative therapeutic strategy. Using a recombinant-antibody phage display library, and SLPs from strain QCD 32g58 as bait antigen, we isolated and extensively characterized 11 SLP-specific recombinant single-domain antibodies (sdAbs), in terms of affinity and specificity, intrinsic stability, and ability to inhibit cell motility. Several sdAbs exhibit promising characteristics for a potential oral therapeutic based on their high affinity, high thermal stability, and resistance to pepsin digestion. Our study provides the basis of a proof-of-principle model with which to develop specific, broadly neutralizing and intrinsically stable antibodies for the oral therapy of C. difficile infections, as an alternative to conventional antibiotic treatment.
Publication date
PublisherUniversity of Ottawa
LanguageEnglish
NRC publication
This is a non-NRC publication

"Non-NRC publications" are publications authored by NRC employees prior to their employment by NRC.

NPARC number21275394
Export citationExport as RIS
Report a correctionReport a correction (opens in a new tab)
Record identifierfd6d0483-0659-4451-aa66-2e4eff3f2b72
Record created2015-06-26
Record modified2020-06-05
Date modified: